| Date Filed | Type | Description |
| 05/13/2009 |
10-Q
| Quarterly Report for the period ended March 31, 2009 |
| 03/31/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/30/2009 |
10-K/A
| Annual Report for the period ended December 31, 2007 [amend] |
| 03/30/2009 |
10-K/A
| Annual Report for the period ended December 31, 2006 [amend] |
| 03/30/2009 |
10-Q/A
| Quarterly Report for the period ended September 30, 2008 [amend] |
| 03/27/2009 |
8-K
| Quarterly results |
| 11/14/2008 |
10-Q
| Quarterly Report for the period ended September 30, 2008 |
| 11/12/2008 |
10-Q/A
| Quarterly Report for the period ended June 30, 2008 [amend] |
| 11/12/2008 |
10-K/A
| Annual Report for the period ended December 31, 2007 [amend] |
| 11/12/2008 |
8-K
| Form 8-K -- Current report |
| 07/31/2008 |
DEFR14C
| Form DEFR14C - Revised information statement materials, definitive: |
| 07/22/2008 |
DEF 14C
| Form DEF 14C - Other definitive information statements |
| 07/11/2008 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials |
| 07/10/2008 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 05/01/2008 |
DEFR14C
| Form DEFR14C - Revised information statement materials, definitive |
| 05/01/2008 |
DEF 14C
| Form DEF 14C - Other definitive information statements |
| 11/29/2007 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/20/2007 |
8-K
| Other Events |
| 11/14/2007 |
SC 13G/A
| VISION OPPORTUNITY MASTER FUND, LTD. has filed a Schedule 13D for China Biopharma, Inc. |
| 11/13/2007 |
8-K
| Appointed CFO |
| 05/22/2007 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 04/16/2007 |
4
| MURRAY JOHN F (CFO) has filed a Form 4 on CHINA BIOPHARMA, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.14, valued at
$21k
|
|
| 04/16/2007 |
4
| WANG QIUMENG (Chief Operation Officer) has filed a Form 4 on CHINA BIOPHARMA, INC.|
Txns:
| Granted 1,200,000 options to buy
@ $0.14, valued at
$168k
|
|
| 04/16/2007 |
8-K
| Appointed CFO |
| 03/26/2007 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 03/26/2007 |
8-K
| Results of Operations and Financial Condition |
| 03/01/2007 |
SC 13G
| VISION OPPORTUNITY MASTER FUND, LTD. reports a 5% stake in China Biopharma, Inc. |
| 12/14/2006 |
8-K/A
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 12/14/2006 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Form of Secured Convertible Promissory Note",
"Form of Class A Warrant",
"Form of Class B Warrant",
"Form of Finder Warrant",
"Subscription Agreement, by and among the Company and the subscribers identified on the signature page thereto",
"Security Agreement, by and between the Company, China Quantum Communications Ltd., China Biopharma Ltd., Guang Tong Wang Luo (China) Co. Ltd., and Barbara R. Mittman, as collateral agent for the Subscribers",
"Guaranty, entered into by the Subsidiaries, for the benefit of the Subscribers" |
|
| 11/14/2006 |
DEF 14C
| Form DEF 14C - Other definitive information statements |
| 11/03/2006 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 06/05/2006 |
8-K
| Entry into a Material Definitive Agreement |
| 04/13/2006 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 02/08/2006 |
8-K
| Changes in Registrant.s Certifying Accountant |
|